info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Septic Arthritis Market is Expected to Grow at a CAGR of 2.10% During the Forecast Period 2022-2030

Pune, India, Nov, 2021 /MRFR Press Release/- Market Research Future has a half cooked research report on the global septic arthritis market. The global Septic arthritis market is growing continuously and expected to grow at a CAGR of 2.10% from 2022 to 2030.


Market Highlights


Septic arthritis is inflammation of joints caused by the bacterial infection. Staphylococcal and Streptococcal bacteria are the most common bacteria that enter the wound and travel into the blood stream to the affect joints leading to inflammation. Septic arthritis causes severe pain, swelling, redness and heat in affected joints. The treatment available for septic arthritis involves the use of antibiotics and surgical procedure such as arthroscopy. 


Rising prevalence of chronic diseases such as rheumatoid arthritis, diabetes and other diseases, extensive demand for the treatment of septic arthritis and increasing number of orthopedic or joint replacement surgeries stimulate the growth of the market.


The Septic Arthritis Market is expected to reach USD 69,448.42 Million by 2030 at 2.10% CAGR during the forecast period 2022-2030.


Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Septic arthritis market research report–Global forecast till 2030.”


Major Players in Septic Arthritis Market:


Some of the key players in the global market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson (U.S.), Pfizer (U.S.).


Regional Analysis


America is the largest market for septic arthritis owing to rising prevalence of obesity and septic arthritis in the U.S., especially among the pediatric population.  According to the National Institute for Diabetes and Digestive and Kidney Disease, in the U.S. more than 1 in 3 adults were overweight during 2013-2014. According to the Center for Disease Control and Prevention, from 2013- 2015, an estimated 54.4 million U.S. adults annually were diagnosed with rheumatoid arthritis, gout, lupus, or fibromyalgia. It also stated that the risk of arthritis increases with age and disease is common in women than in men.


Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis and obesity in European countries and availability of funds for research and development activities. According to the World Health Organization (WHO), in European Union countries, nearly 30-70% of the population is obese.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by rising geriatric population, and high prevalence of chronic disease such as diabetes, and obesity. Diabetes is one of the major problems in Asia Pacific further creating opportunities for the market growth. According to the International Diabetes Foundation, 98.4 million and 65.1 million diabetic patients live in China and India respectively.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.


Segmentation


The global septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.


On the basis of diagnosis, market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI and CT scan.


On the basis of treatment, the market is segmented into antibiotics, aspiration of the joint, surgery and others. Surgery is further segmented into arthrotomy and arthroscopy.


On the basis of indication, the market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery and others.


On the basis of end user, the market is segmented into orthopedic hospitals, clinics, pharmaceutical companies and others.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of  Septic Arthritis Market Research Report

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Companies Covered 15
Pages 110
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.